Beyond the Great Wall: Unlocking China's Medical Device Market in 2025

China's medical device market is poised for significant growth leading into 2025, driven by an aging population and government initiatives like "Healthy China 2030." However, foreign manufacturers face new challenges, including fierce local competition, pro-domestic procurement policies, and the complexities of the NMPA regulatory system. This episode breaks down the market outlook for 2025, exploring the key drivers, the critical challenges, and the localized strategies required to succeed in this evolving landscape. Key Questions: • What are the latest growth forecasts for China's MedTech market in 2025 and beyond? • How is the "Healthy China 2030" policy impacting opportunities for foreign companies? • Why is a "Made in China" strategy becoming essential for market access? • What are the biggest regulatory hurdles presented by the NMPA? • How is the rise of local competitors and Volume-Based Procurement (VBP) affecting pricing and strategy? • Which device categories, such as AI and robotics, show the most promise for foreign brands? • What are the most effective market entry models for navigating the 2025 landscape? • Is it still possible for international medical device companies to succeed in China? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.